scispace - formally typeset
Search or ask a question

Showing papers by "Vadim A. Soloshonok published in 2022"


Journal ArticleDOI
TL;DR: In this article , the authors presented a review of nine fluorine-containing drugs that have been approved by the US Food and Drug Administration (FDA) in 2021, which feature aromatic fluorine, trifluoromethyl and chlorodifluoro groups.

60 citations


Journal ArticleDOI
TL;DR: The primary goal of this work is to underscore two major trends in the design of modern pharmaceuticals: the unique structural characteristics provided by the structure of amino acids featuring an abundance of functionality and the presence of a stereogenic center, all of which bodes well for the successful development of targeted bioactivity.
Abstract: Nowadays, the selective introduction of fluorine into bioactive compounds is a mature strategy in the design of drugs allowing to increase efficiency, biological half-life and bio-absorption. On the other hand, amino acids (AAs) represent one of the most ubiquitious classes of naturally occurring organic compounds, which are found in over 40% of newly marked small-molecule pharmaceutical drugs and medical formulations. The primary goal of this work is to underscore two major trends in the design of modern pharmaceuticals. The first is dealing with the unique structural characteristics provided by the structure of amino acids featuring an abundance of functionality and the presence of a stereogenic center, all of which bodes well for the successful development of targeted bioactivity. The second is related to fine-tuning the desired activity and pharmacokinetics by selective introduction of fluorine. Historically, both trends were developed separately as innovative and prolific approaches in modern drug design. However, in recent decades, these approaches are clearly converging leading to an ever-increasing number of newly approved pharmaceuticals containing both structural features of amino acids and fluorine.

7 citations


Journal ArticleDOI
TL;DR: This review critically discusses the literature data reported on the preparation of substituted GABA derivatives using the Michael addition reaction as a key synthetic transformation and pays special attention to asymmetric methods featuring synthetically useful stereochemical outcomes and operational simplicity.
Abstract: γ-Aminobutyric acid (GABA) represents one of the most prolific structural units widely used in the design of modern pharmaceuticals. For example, β-substituted GABA derivatives are found in numerous neurological drugs, such as baclofen, phenibut, tolibut, pregabalin, phenylpiracetam, brivaracetam, and rolipram, to mention just a few. In this review, we critically discuss the literature data reported on the preparation of substituted GABA derivatives using the Michael addition reaction as a key synthetic transformation. Special attention is paid to asymmetric methods featuring synthetically useful stereochemical outcomes and operational simplicity.

7 citations


Journal ArticleDOI
TL;DR: In this paper , a review of trifluoromethoxy-containing molecules represents still underdeveloped, but highly promising group of biologically active compounds, and the authors discuss the detailed chemical synthesis and general aspects of biological activity.

4 citations


Journal ArticleDOI
TL;DR: An operationally simple and convenient resolution method via Cu(II) complexes was reported, efficiently providing valuable enantiopure N,C-unprotected α-amino acids, and biological evaluation indicated that they were effective against most of Gram-positive bacteria.
Abstract: An operationally simple and convenient resolution method via Cu(II) complexes was reported, efficiently providing valuable enantiopure N,C-unprotected α-amino acids. This protocol features synthetically attractive yields and a stereochemical outcome, using a recyclable Schiff base ligand and inexpensive easily accessible metal copper salts. These novel Cu(II) complexes can be obtained in an enantiopure state by means of column chromatography or recrystallization. Furthermore, all the Cu(II) complexes were evaluated for their antibacterial activities. Among them, complexes (S,2S)-3a, (S,2S)-3g, and (S,2S)-3o showed significant antibacterial activities against Staphylococcus aureus Mu50. Further biological evaluation indicated that they were effective against most of Gram-positive bacteria. It is the first study on the biological activities of transition metal complexes with this type of proline-derived Schiff base ligand.

1 citations